|

Albumin-Bound Paclitaxel /nab-Paclitaxel Clinical Trials

3 actively recruiting trials

▲ +1 trial since June 2026

Also known as: docetaxel

Pipeline

Phase 2: 3

Top Sponsors

  • The First Affiliated Hospital with Nanjing Medical University1
  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1
  • Eye & ENT Hospital of Fudan University1

Indications

  • Cancer3
  • Head Neck Cancer1
  • Biliary Tract Neoplasms1
  • Hypopharyngeal Carcinoma1
  • Head and Neck Squamous Cell Carcinoma (HNSCC)1

Other3 trials

An Open-label, Single-arm, Multicenter Exploratory Study of Adebrelimab Combined With Gemcitabine and Albumin-bound Paclitaxel as First-line Treatment for Biliary Tract Malignancies
Phase 2
Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma
Phase 2
Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.